Eythorsson et al.'s Iceland study had very early on shown us what we knew about the mRNA technology gene injections (Pfizer, Moderna) failing & driving more infection in the vaccinated, SAME as what

Shrestha et al. found in the Cleveland Clinic study, a clear dose response (see below) & no vaccine, less infection; Eythorsson showed 11.5% re-infection during Omicron with mRNA vaccine

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794886?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080322

Eythorsson:

‘In total, 11 536 PCR-positive persons were included. The mean (SD) age was 34 (19) years (median, 31 years; range, 0-102 years), 5888 (51%) were male, 2942 (25.5%) had received at least 1 dose of vaccine, and the mean (SD) time from initial infection was 287 (191) days (median, 227 days; range, 60-642 days). Reinfection was observed in 1327 persons (11.5%) during the Omicron period.

The reinfection rate was highest (475 of 3136 individuals [15.1%]) among those aged 18 to 29 years. Fewer reinfections occurred among older individuals (Table).

The probability of reinfection increased with time from the initial infection (odds ratio of 18 months vs 3 months, 1.56; 95% CI, 1.18-2.08) (Figure) and was higher among persons who had received 2 or more doses compared with 1 dose or less of vaccine (odds ratio, 1.42; 95% CI, 1.13-1.78).’

Shrestha:

Did Shrestha et al. (Cleveland Clinic study) show that the more COVID boosters received, the higher the risk of subsequently contracting COVID? Yes! There was a clear dose response where the least

DR. PAUL ALEXANDER

·

JUN 17

https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5 ‘Among 51017 working-aged Cleveland Clinic employees, the bivalent COVID-19 vaccine was 29% effective in preventing infection while the BA.4/5 lineages were dominant, and 20% effective while the BQ lineages were. Effectiveness was not demonstrated when the XBB lineages were dominant.’

Read full story

Enlarged:

https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5.full.pdf

see also prior infection status in Shrestha’s study aka natural immunity potency: